The First Face Transplant: The Face of Isabelle Dinoire

IF 0.2 Q4 TRANSPLANTATION
Sri Harsha Boppana, Shreya Sriram, Godugu Swathi, L. V. Simhachalam Kutikuppala, S. V. Kalyani Ponnaganti, Sai Kiran Kuchana
{"title":"The First Face Transplant: The Face of Isabelle Dinoire","authors":"Sri Harsha Boppana, Shreya Sriram, Godugu Swathi, L. V. Simhachalam Kutikuppala, S. V. Kalyani Ponnaganti, Sai Kiran Kuchana","doi":"10.4103/ijot.ijot_62_22","DOIUrl":null,"url":null,"abstract":"Dear Editor, Since the 1990s, face transplants have received a great deal of press and public attention around the world. Isabelle Dinoire, the first woman who received a face transplant, became the center of attraction after undergoing an innovative surgical procedure. The first ethical approval for a face transplant in the world, was obtained by Agich and Siemionow’s team at the Cleveland Clinic in Ohio. The approach of Ohio scientists was based on more of a practical approach performed by a surgical team in Amiens, France.[1] Benoit Lengele, one of the surgeons involved, speculated a premeditated strategy, for the entire team to surreptitiously complete the process and contemplate each step thoroughly. Bernard Devauchelle was the pioneer in maxillofacial surgery. He and his team along with Jean-Michel Dubernard, a French pioneer transplant specialist have executed the first hand transplant on on November 27, 2005.[2] Unlike previous attempts, the French team submitted a case-by-case proposal for Dinoire rather than on behalf of hypothetical patients. Dinoire’s psychological and physical rehabilitation was aided by an interdisciplinary team based in Lyon and Amiens, and the procedure was not made public until after it had taken place. Because the procedure was leaked to a British newspaper, the face transplant became public much sooner than the team had planned.[3] After the continuous medical procedures, there was transmogrification in social, ethical, and clinical disagreements. After the initial facial transplant, the pool of thoughts drifted to immediate postoperative care rather than the indications of the surgery. Dinoire was apparently asymptomatic in the postoperative period and was completely fit both immunologically and functionally. She was able to perform all her duties within 12 weeks of the posttransplant period.[4] After 5 years of surgical innovation, Dinoire encountered that she was not able to eat, drink, or talk normally, but in subsequent publications around the same time, the surgeons emphasized the psychological and social benefits of undergoing a transplant over the functional issues Dinoire faced with a passing mention of her new life by virtue of her new face. The surgeons mainly focused on cosmetic outcomes. Functional and immunological outcomes were not emphasized despite the fact that she had previously been treated for two episodes of acute rejection. She also had renal failure and cervical cancer which could have stemmed from immunosuppressive medication. Dinoire died of lung cancer on April 1, 2016, at the age of 49.[5] Apprehending the importance of additional facial transplants, The Royal College of Surgeons delineated exigencies for successful facial transplants. Nonetheless, Peter Butler on October 25, 2006, the day before the publication of exigencies received ethical clearance from Royal Hospital, London, for performing four facial transplants. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.","PeriodicalId":37455,"journal":{"name":"Indian Journal of Transplantation","volume":"71 1","pages":"0"},"PeriodicalIF":0.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Transplantation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijot.ijot_62_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"TRANSPLANTATION","Score":null,"Total":0}
引用次数: 0

Abstract

Dear Editor, Since the 1990s, face transplants have received a great deal of press and public attention around the world. Isabelle Dinoire, the first woman who received a face transplant, became the center of attraction after undergoing an innovative surgical procedure. The first ethical approval for a face transplant in the world, was obtained by Agich and Siemionow’s team at the Cleveland Clinic in Ohio. The approach of Ohio scientists was based on more of a practical approach performed by a surgical team in Amiens, France.[1] Benoit Lengele, one of the surgeons involved, speculated a premeditated strategy, for the entire team to surreptitiously complete the process and contemplate each step thoroughly. Bernard Devauchelle was the pioneer in maxillofacial surgery. He and his team along with Jean-Michel Dubernard, a French pioneer transplant specialist have executed the first hand transplant on on November 27, 2005.[2] Unlike previous attempts, the French team submitted a case-by-case proposal for Dinoire rather than on behalf of hypothetical patients. Dinoire’s psychological and physical rehabilitation was aided by an interdisciplinary team based in Lyon and Amiens, and the procedure was not made public until after it had taken place. Because the procedure was leaked to a British newspaper, the face transplant became public much sooner than the team had planned.[3] After the continuous medical procedures, there was transmogrification in social, ethical, and clinical disagreements. After the initial facial transplant, the pool of thoughts drifted to immediate postoperative care rather than the indications of the surgery. Dinoire was apparently asymptomatic in the postoperative period and was completely fit both immunologically and functionally. She was able to perform all her duties within 12 weeks of the posttransplant period.[4] After 5 years of surgical innovation, Dinoire encountered that she was not able to eat, drink, or talk normally, but in subsequent publications around the same time, the surgeons emphasized the psychological and social benefits of undergoing a transplant over the functional issues Dinoire faced with a passing mention of her new life by virtue of her new face. The surgeons mainly focused on cosmetic outcomes. Functional and immunological outcomes were not emphasized despite the fact that she had previously been treated for two episodes of acute rejection. She also had renal failure and cervical cancer which could have stemmed from immunosuppressive medication. Dinoire died of lung cancer on April 1, 2016, at the age of 49.[5] Apprehending the importance of additional facial transplants, The Royal College of Surgeons delineated exigencies for successful facial transplants. Nonetheless, Peter Butler on October 25, 2006, the day before the publication of exigencies received ethical clearance from Royal Hospital, London, for performing four facial transplants. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
第一个面部移植手术:伊莎贝尔·迪诺瓦的脸
亲爱的编辑,自20世纪90年代以来,面部移植在世界各地受到了大量的媒体和公众关注。第一位接受面部移植手术的女性伊莎贝尔·迪诺瓦在接受了一项创新的外科手术后成为了人们关注的焦点。俄亥俄州克利夫兰诊所的Agich和Siemionow的团队获得了世界上第一个关于面部移植的伦理批准。俄亥俄科学家的方法是基于法国亚眠的一个外科团队所采用的更实用的方法。[1]参与手术的外科医生之一贝努瓦·朗格勒(Benoit Lengele)设想了一个有预谋的策略,让整个团队秘密地完成整个过程,并仔细考虑每一步。Bernard Devauchelle是颌面外科的先驱。2005年11月27日,他和他的团队以及法国先驱移植专家让-米歇尔·杜伯纳德(Jean-Michel Dubernard)完成了首例手部移植手术。[2]与以前的尝试不同,法国团队为迪诺瓦提交了一个具体案例的建议,而不是代表假想的病人。迪诺瓦的心理和身体康复是由里昂和亚眠的一个跨学科团队协助进行的,直到手术完成后才对外公布。由于手术过程被泄露给了一家英国报纸,面部移植手术比团队计划的要早得多。[3]在持续的医疗程序之后,社会、伦理和临床的分歧都发生了变化。在最初的面部移植手术后,人们的注意力都集中在术后护理上,而不是手术的适应症上。Dinoire术后无明显症状,在免疫和功能上完全适应。她能够在移植后的12周内履行所有职责。[4]经过5年的手术革新,Dinoire发现她不能正常地吃、喝或说话,但在大约同一时间的后续出版物中,外科医生强调了接受移植的心理和社会效益,而不是Dinoire面临的功能问题,并通过她的新面孔提到了她的新生活。外科医生主要关注美容效果。功能和免疫结果没有强调,尽管事实上,她之前曾治疗过两次急性排斥反应。她还患有肾衰竭和宫颈癌,这可能是由免疫抑制药物引起的。2016年4月1日,迪诺瓦因肺癌去世,享年49岁。[5]认识到额外的面部移植的重要性,皇家外科医师学会描述了成功的面部移植的紧急情况。尽管如此,彼得·巴特勒在2006年10月25日,也就是紧急事件发表的前一天,接受了伦敦皇家医院的道德许可,进行了四次面部移植手术。财政支持及赞助无。利益冲突没有利益冲突。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Indian Journal of Transplantation
Indian Journal of Transplantation Medicine-Transplantation
CiteScore
0.40
自引率
33.30%
发文量
25
审稿时长
21 weeks
期刊介绍: Indian Journal of Transplantation, an official publication of Indian Society of Organ Transplantation (ISOT), is a peer-reviewed print + online quarterly national journal. The journal''s full text is available online at http://www.ijtonline.in. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository. It has many articles which include original articIes, review articles, case reports etc and is very popular among the nephrologists, urologists and transplant surgeons alike. It has a very wide circulation among all the nephrologists, urologists, transplant surgeons and physicians iinvolved in kidney, heart, liver, lungs and pancreas transplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信